How do we determine what a fair price for a life-saving prescription medication should be? This month, we discuss what is means for a price to be “fair” and explore the current legal and economic landscape of prescription drug pricing in the US.
Debbie Berkowitz joins Ethics Talk to discuss her article, coauthored with Anna D. Goff, Dr Kathleen Marie Fagan, and Dr Monica L. Gerrek: "Do Clinics in Meat and Poultry Plants Endanger Workers?”
Dr Lisa Lehmann joins Ethics Talk to discuss “grateful patient programs,” pressures clinicians face to fundraise on behalf of health care organizations for which they work, and whether “VIP” care really is better for patients.
Dr Kimberly A. Singletary joins Ethics Talk to discuss her article, coauthored with Dr Marshall H. Chin: “What Should Antiracist Payment Reform Look Like?”
Dr Ala Shaikhkhalil joins Ethics Talk to discuss her article, coauthored with Drs Ethan A. Mezoff and Hannah Hays: “Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D?”
Professor Martin Bricknell joins Ethics Talk to discuss his article, coauthored with Professors David Whetham, Richard Sullivan, and Peter Mahoney: “How Should Access to Military Health Care Facilities Be Controlled in Conflict?”
Dr Hunter Jackson Smith joins Ethics Talk to discuss his article, coauthored with Joseph Procaccino and Dr Megan Applewhite: “How Should Military Health Care Workers Respond When Conflict Reaches the Hospital?”
Dr Ghassan S. Abu-Sittah joins Ethics Talk to discuss his article, coauthored with Dr Thalia Arawi and Bashar Hassan: “Everyone Is Harmed When Clinicians Aren’t Prepared”
